Molecular Biological Markers for Toxicology and Risk Assessment
Autor Bruce A. Fowleren Limba Engleză Hardback – 7 iun 2016
Molecular Biological Markers for Toxicology and Risk Assessment guides the reader through a broad range of molecular biological markers, including the "omic" biomarkers, and provides an examination of the various elements in the evolution of these modern tools. It then explores possible ways in which these markers may be applied to advance the field of chemical risk assessment. Since molecular biomarkers and related technologies are inherently complex, the book concludes with a section on risk communication in order that readers may appreciate both the strengths and limitations of molecular biological marker approaches to risk assessment practice.
- Introduces the use of molecular biomarkers to detect toxic effects of chemicals as early as possible
- Provides an accessible overview of this emerging, interdisciplinary field, to best inform decision making in chemical and pharmaceutical safety
- Includes a section on risk communication of these complex concepts, essential for effective risk assessment
- Provides new insights into the initial mechanisms of chemical-induced toxicity and carcinogenicity
Preț: 483.82 lei
Preț vechi: 509.28 lei
-5% Nou
Puncte Express: 726
Preț estimativ în valută:
92.59€ • 97.10$ • 77.20£
92.59€ • 97.10$ • 77.20£
Carte tipărită la comandă
Livrare economică 01-15 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128095898
ISBN-10: 012809589X
Pagini: 164
Dimensiuni: 191 x 235 x 15 mm
Greutate: 0.54 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 012809589X
Pagini: 164
Dimensiuni: 191 x 235 x 15 mm
Greutate: 0.54 kg
Editura: ELSEVIER SCIENCE
Public țintă
Professional toxicologists, risk assessors, and regulatorsCuprins
Preface1. Introduction2. Historical Development of Biomarkers3. Computational Toxicology4. Omic Biological Markers5. Validation of Biological Markers for Epidemiological Studies6. Technical Translational Analysis of Biological Marker Data7. QA/QC of Biological Marker Data Sets8. Translation of Biomarkers for Human Clinical and Epidemiological Studies9. Risk Communication of Molecular Biological Marker Information10. Future Research DirectionsAppendices